Login
$CRDL
$1.00 +$0.02 (2.06%) After hours

Company Executives

Officer In this role Source
David Elsley Also a director
Director, President and Chief Executive Officer
Not stated
Chris Waddick Also a director
Director, Chief Financial Officer and Corporate Secretary
Not stated
Bernard Lim
Chief Operating Officer
Since 2020
6 years
Andrew Hamer
Chief Medical Officer and Head of Research and Development
Since 2021
5 years

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 40-F annual report

Directors
8
serving now
Independent
4 of 4
stated in the proxy; 4 not stated
Average tenure
5.3 years
from year joined
CEO also chairs the board
No
Guillermo Torre-Amione
Director On board Independent Committees Pay Source
Guillermo Torre-Amione
2018
8 years
Not stated None stated Not stated
David Elsley
Not stated Not stated None stated Paid as CEO
Chris Waddick
2022
4 years
Not stated None stated Not stated
Peter Pekos
2017
9 years
Not stated None stated Not stated
Colin Stott
2019
7 years
Independent
Audit Committee
Not stated
Jennifer Chao
2022
4 years
Independent None stated Not stated
Teri Loxam
2022
4 years
Independent
Audit Committee · Chair
Not stated
Timothy Garnett
2025
1 year
Independent
Audit Committee
Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. Cardiol Therapeutics Inc. has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support